[Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis]
- PMID: 16405752
[Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis]
Abstract
Background & objective: Positron emission tomography-computed tomography (PET-CT) is a new bio-imaging system which combined metabolic with anatomic imaging. This system has better three-dimensional definition and earlier tumor detection potential. This study was to compare the accuracy of tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis and staging.
Methods: A total of 43 lung cancer patients diagnosed by operation or acupuncture, received breast CT scan, tumor antigen detection, and PET-CT scan, were selected. The accuracies of these 2 methods and their impacts on lung cancer staging were compared.
Results: The accurate diagnosis rate of tumor antigen detection combined with CT scan was 67.44%, and that of PET-CT scan was 90.70%. Local focus detection rates were 86.05% and 95.35%, respectively; mediastinal lymph nodes detection rates were 65.12% and 83.72%, respectively. PET-CT detected 6 cases of distant metastasis which were not detected by tumor antigen detection combined with CT scan. Compared with CT scan, 5 (11.63%) cases were upstaged and 7 (16.28%) cases were downstaged by PET-CT, which led to therapeutic strategy changes in 4 (9.3%) cases.
Conclusion: Compare with tumor antigen detection combined with CT scan, PET-CT scan is more sensitive and accurate in diagnosing and staging lung cancer.
Similar articles
-
Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.Jpn J Clin Oncol. 2006 Nov;36(11):694-8. doi: 10.1093/jjco/hyl092. Epub 2006 Oct 26. Jpn J Clin Oncol. 2006. PMID: 17068084
-
Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation.Lung Cancer. 2011 Jul;73(1):59-62. doi: 10.1016/j.lungcan.2010.10.021. Epub 2010 Nov 20. Lung Cancer. 2011. PMID: 21094559
-
FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.Ann Thorac Cardiovasc Surg. 2006 Apr;12(2):89-94. Ann Thorac Cardiovasc Surg. 2006. PMID: 16702929 Clinical Trial.
-
[Diagnosis of lung cancer. Role of PET/CT fusion scan in lung cancer].Rev Mal Respir. 2006 Nov;23(5 Pt 3):16S11-16S16. Rev Mal Respir. 2006. PMID: 17268330 Review. French.
-
Imaging lung cancer.Semin Oncol. 1999 Oct;26(5 Suppl 15):21-6. Semin Oncol. 1999. PMID: 10566607 Review.
Cited by
-
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.Cochrane Database Syst Rev. 2014 Nov 13;2014(11):CD009519. doi: 10.1002/14651858.CD009519.pub2. Cochrane Database Syst Rev. 2014. PMID: 25393718 Free PMC article.